baber/WOPTO huggingface dataset:
Patent AU-2020225325-A1 (AU)
Title: Wideband antenna, in particular for a microwave imaging system
Inventor: MANNESCHI ALESSANDRO
IPC: H01Q1/38
Filed: 2020-02-18
Abstract: The present invention relates to an antenna structure that is integrated into a printed circuit (10) comprising two dielectric layers (52, 56) that have the same dielectric constant but different thicknesses, a balanced radiating element in a spiral (60) on the first face (51) of the first dielectric layer (52) and a power supply for the balanced antenna by a balanced two-wire line (70) which has the same impedance as the balanced antenna, characterized in that the balanced two-wire line (70) interconnects the balanced spiral antenna (60) to a pair of microstrip transmission lines (80) positioned on the second face (57) of the second layer (56), in which each microstrip line (80) is suitable for having an impedance that is equal to half the impedance of the two-wire transmission line (70), and in that, in correspondence with the balanced microstrip line (80) on the first face (55) of the second layer (56) corresponding to the second face (53) of the first layer (52), a ground plane is positioned (85) which determines, as a function of the thickness of the second dielectric layer (56) and the distance between the microstrips (80), the transmission impedance of the balanced microstrip line.
Patent AU-2020244803-A1 (AU)
Title: Methods for treating muscular dystrophy with casimersen
Inventor: KAYE EDWARD M
IPC: A61P43/00
Filed: 2020-03-25
Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 45 skipping by administering an effective amount of casimersen.
Patent AU-2020264438-A1 (AU)
Title: Intrathecal and intravenous combination gene therapy for the treatment of infantile batten disease
Inventor: MILLER TIMOTHY J
IPC: A61P25/08
Filed: 2020-04-29
Abstract: Methods for treating IBD or an IBD related disorder in a subject in need thereof are provided that comprise combined intrathecal administration of a polynucleotide comprising a CLN1 open reading frame and intravenous administration of the polynucleotide. The polynucleotide comprising the CLN1 open reading frame is a wild-type CLN1 polynucleotide. In another aspect, the polynucleotide comprising the CLN1 open reading frame comprises codon-optimized polynucleotide sequence of the polynucleotide or its complement and is codon-optimized for expression in a human cell.
Patent AU-2020266560-A1 (AU)
Title: Cancer associated antibody compositions and methods of use
Inventor: BIASCI DANIELE
IPC: C07K16/30
Filed: 2020-04-29
Abstract: The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the diagnosis of a cancer or a metastasis thereof. The disclosure herein relates to novel cancer-associated antibodies and antigen-binding fragments that are used in the treatment of a cancer or a metastasis thereof. The disclosure herein relates to novel chimeric antigen receptor or a T cell receptor fusion protein that comprise one or more cancer-associated antigen-binding domains that are useful for the treatment of a cancer.
Patent AU-2020287396-A1 (AU)
Title: Processes for extracting lignin from black liquor
Inventor: BOHRER LOBOSCO GONZAGA DE OLIVEIRA VINÍCIUS
IPC: D21C11/00
Filed: 2020-06-01
Abstract: The present invention relates to processes for extracting lignin from black liquor. In particular, processes for both extracting acidic lignin and extracting alkaline lignin from black liquor are disclosed, comprising: precipitating lignin by acidification of black liquor; adjusting the temperature to above 60°C; cooling; separation; and displacement washing and/or washing by ion exchange.
Patent AU-2020295715-A1 (AU)
Title: Ultramodular IgG3-based spacer domain and multi-function site for implementation in chimeric antigen receptor design
Inventor: HUDECEK MICHAEL
IPC: C07K16/00
Filed: 2020-06-19
Abstract: The invention generally relates to immunotherapy using immune cells such as chimeric antigen receptor (CAR)-engineered T cells. In particular, the invention relates to immunotherapy using chimeric antigen receptor (CAR)-engineered T cells that carry a novel, IgG3-Hinge-based spacer domain, allowing a finely modulated response to target antigens. In addition, the invention relates to the introduction of one or more IgG3-Hinge-based multi- function sites (MFs) into CARs and other immunoreceptors, allowing purification, stimulation, expansion and depletion of CAR T cells. The invention includes also the sequence of an antibody targeting this motif, allowing the execution of the before- mentioned functions.
Patent AU-2020296012-A1 (AU)
Title: Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonist
Inventor: SKOLNICK PHIL
IPC: C07C203/04
Filed: 2020-06-17
Abstract: Disclosed herein are formulations and methods for reversing one or more symptoms of cannabinoid hyperemesis syndrome (CHS) or one or more symptoms thereof, comprising parenterally administering a CB1 antagonist in an amount sufficient to reverse the CHS or symptom(s).
Patent AU-2020296950-A1 (AU)
Title: Compression bandage and compression bandage combination
Inventor: TAMOUÉ FERDINAND
IPC: A61F13/08
Filed: 2020-06-22
Abstract: The invention relates to a compression bandage comprising a nonwoven-based bandage layer that has been stitched over with elastic textile threads by stitch bonding methods, the textile threads being heat-shrinkable and not elastomeric and the compression bandage having an elasticity after heat shrinking of the textile threads by 50-200%, particularly 50% to 90% and especially 50% to 70%. The invention also relates to a compression bandage combination.
Patent AU-2020386146-A1 (AU)
Title: Matrix resin for laminates with high transparency, low yellowing and high glass transition temperatures
Inventor: MARKOU KONSTANTINOS
IPC: C08J5/24
Filed: 2020-11-19
Abstract: The present invention relates to curable resin compositions, to methods for producing cured compositions using said curable resin compositions, and articles, in particular mouldings, produced according to said type of methods.
Patent AU-2020450941-A1 (AU)
Title: Hydroelectrically-charged agricultural hose reel prime mover, mobile agricultural irrigation system including the same, and hydroelectrically-charged agricultural traveling gun prime mover
Inventor: MOHR DANA
IPC: A01G25/09
Filed: 2020-05-28
Abstract: A hydroelectrically-charged hose reel prime mover [100] includes: a carriage [105]; a plurality of wheels [101/102] coupled to the carriage [105]; a hose reel [140] rotatably connected to the carriage [105]; a flexible hose [141] configured to receive a pressurized fluid, the flexible hose [141] arranged on the hose reel [140] and open into a turbine inlet pipe [123]; an electric drive system; and a hydroelectric charging system. The electric drive system including: a battery pack [132] and a motor [133] electrically connected to the battery pack [132] and configured to rotate at least some of the wheels [102], The hydroelectric charging system including a turbine [128] fluidly connected to the turbine inlet pipe [123] to receive at least some of the pressurized fluid via the flexible hose [141] and a hydroelectric generator [129] connected to the turbine [128], The hydroelectric generator [129] is configured to charge the battery pack [132],
Patent WO-2021203168-A1 (WO)
Title: Treatment for sepsis-induced organ dysfunction
Inventor: BELLOMO RINALDO
IPC: A61P31/04
Filed: 2021-04-08
Abstract: Provided herein are methods for treating or preventing a condition, and/or symptom or clinical manifestation, associated with systemic infection wherein a subject is intravenously administered ascorbic acid or a pharmaceutically acceptable salt, ester or isomer thereof in an amount of between about 700 mg/kg body weight and about 4,000 mg/kg body weight per day, optionally as a first bolus infusion followed by a subsequent continuous infusion. Also provided are methods comprising intravenously administering to the subject ascorbic acid or a pharmaceutically acceptable salt, ester or isomer thereof: (i) as a bolus dose of from about 350 mg/kg body weight to about 500 mg/kg body weight; and (ii) following (i), by continuous infusion over at least several hours at a dose of from about 60 mg/kg body weight/hr to about 500 mg/kg body weight/hr. Typically, the condition is sepsis or septic shock.
Patent AU-2021218012-A1 (AU)
Title: Targeting bcl11a distal regulatory elements for fetal hemoglobin reinduction
Inventor: ORKIN STUART H
IPC: C12N5/0789
Filed: 2021-08-16
Abstract: Provided herein are methods and compositions for increasing fetal haemoglobin levels in a cell by 
disrupting BCL11A expression at the genomic level. Also provided herein are methods and 
compositions relating to the treatment of hemoglobinopathies by reinduction of fetal haemoglobin 
levels. Also provided are DNA-targeting endonuclease comprising a TAL binding domain, wherein 
the DNA targeting endonuclease binds and cleaves the genomic DNA of the cell on chromosome 2 
location 60,716,189-60,728,612 to generate the at least one genetic modification therein that disrupts 
DNAse hypersensitive sites +62, +58, or +55.
Patent AU-2021221676-A1 (AU)
Title: Method for preparing organic coated feed (for pet) using clay mineral and organic matter
Inventor: KWAK SUNG GUN
IPC: A23K20/20
Filed: 2021-08-25
Abstract: Disclosed is a method for preparing organic coated feed (for 
pets) using clay minerals, organic matter and the like. According 
5 to the present invention, a feed with a decreased odor and high 
preference is provided by the utilization of Macsumsuk and oriental 
medicine extracts. In addition, people living in the same living 
space as pets hardly smell the unpleasant odor of feed.
3/4 
SEM image 
(x 300) 
Testing institution: International Certified Laboratory Korea Polymer Testing & Research Institute 
FIG. 3
Patent AU-2021229979-A1 (AU)
Title: Crystal of tricyclic compound acting on CRBN protein and preparation method therefor
Inventor: LEI MAOYI
IPC: A61K31/42
Filed: 2021-03-05
Abstract: Disclosed are a crystal of a tricyclic compound acting on CRBN protein and a preparation method therefor, specifically relating to a crystal of a compound of formula (I) and a preparation method therefor. An application of the crystal in the preparation of drugs for treating CRBN protein-related diseases is further comprised.
Patent AU-2021248204-A1 (AU)
Title: Method for editing target RNA
Inventor: ICHINOSE Mizuho
IPC: C12N5/10
Filed: 2021-03-31
Abstract: Provided is a method for converting an editing target C contained in a target RNA into U, or an editing target U therein into C. A method for editing a target RNA, said method comprising applying to the target RNA a synthetic DYW protein that contains a DYW domain comprising one of the following polypeptides a, b, c and bc: a. a polypeptide that has x
Patent AU-2021257890-A1 (AU)
Title: Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs therefor
Inventor: ARTERO ALLEPUZ RUBÉN D
IPC: C12N15/113
Filed: 2021-10-25
Abstract: MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND 
ANTAGONISTS OF MICRORNAS THEREFOR 
ABSTRACT 
Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs 
therefor. The invention provides the use of inhibitors of microRNAs repressors of MBNL1 
and/or MBNL2 genes for the manufacture of a medicinal product for the treatment of myotonic 
dystrophy 1. Inhibiting these microRNAs allows to increase the endogenous levels of the 
corresponding proteins MBNL1 and/or MBNL2, thereby alleviating symptoms of the disease, 
especially when inhibiting repressors that are expressed in the main affected organs: skeletal 
muscle, heart or organs of the central nervous system. The inhibition of the microRNAs miR
23b-3p and miR-2 1 8-5p is preferred. It also provides oligoribonucleotide or oligoribonucleotide 
analogue antagonists suitable therefor, preferably antagomiRs directed against the microRNAs 
mentioned with chemical modifications that enhance their interaction with the target, their 
stability in vivo and their ability to penetrate into the cells and distribute throughout tissues and 
organs.
Patent AU-2021258475-A1 (AU)
Title: Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
Inventor: SHAO ZHIXIN
IPC: C07K16/18
Filed: 2021-04-23
Abstract: The present invention relates to proteins, particularly antibodies such as anti-CD20/anti-CD3 bispecific antibodies and anti α-synuclein antibodies, having monogalactosylated (G1) and digalactosylated (G2) glycans. More particular, the present invention relates to galactosylation engineering to generate proteins with improved therapeutic properties, including proteins with increased titer. Further, the invention relates to a cell culture medium and a mammalian cell as well as methods using said cell culture medium and said mammalian cell for producing said proteins. Moreover, the present invention relates to the use of said antibodies as a medicament such as for the treatment of cancer, particularly cancer associated with B-cells, or Parkinson's disease.
Patent AU-2021283585-A1 (AU)
Title: Inhibitors of KRAS G12C protein and uses thereof
Inventor: SHAN BO
IPC: A61P35/00
Filed: 2021-06-03
Abstract: Provided are novel compounds useful as inhibitors of the KRAS protein, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.
Patent AU-2021290236-A1 (AU)
Title: Formulations of L-ornithine phenylacetate
Inventor: WANG LAURENE
IPC: A61K31/195
Filed: 2021-12-21
Abstract: FORMULATION OF L-ORNITHINE PHENYLACETATE 
Abstract 
Mean Plasna PAA Cocentraion vs Time Picts 
120 
II"J 
0 4 0 10 12 1.1 Is 18 20 22 24 Nf 
Nt1hfa rWi" Tams frm as chur) 
Treatrne k A A sge 5 g a tl d Ws atCR-C1[2 Wal eclu:0ia A dristrd urder asung tandison 
Treament S: A single 5 9 oral dasa of COR-002 aral soluton adminisieredj under fad conln 
Treatment r- A e rgle 5 g irtraawiru dose t C'R-002 salutien refused nver 1 houjr under feAng rmidibors 
Trvlienl, D. A si4iu s g wai def or o im m2 utt4 somilon iudmied uriderfliyadlm lovl dler illilisin 
af Iteuse 
FRICURE 3 
Some embodiments of the present application are directed to oral formulations 
of L-ornithine phenylacetate and methods of using the same. These oral formulations 
offer alternative administration route than the standard intravenous administration of 
L-ornithine phenylacetate for treating hyperammonemnia in patients having various 
acute and chronic liver diseases and disorders, for example, acute liver failure, liver 
cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or 
patients with urea cycle disorders.
Patent AU-2021290431-A1 (AU)
Title: Image processing method, apparatus and device, and storage medium
Inventor: ZHANG WENBIN
IPC: G06T7/70
Filed: 2021-12-21
Abstract: Provided are an image processing method, apparatus and device, and a storage medium.  
The method includes following operations: from multiple images of a preset scene, total 
information of picture content in each of the multiple images is acquired; among the multiple 
images, at least two first images in which a change in picture content meets a preset condition 
are determined based on the total information of the picture content in the multiple images; 
incremental information of an object that changes is determined in the at least two first images; 
and the incremental information is fed to an upper-layer service to enable the upper-layer 
service to conduct a service related to the object based on the incremental information.
Patent AU-2021297464-A1 (AU)
Title: Methods for deriving dopaminergic neurons from pluripotent stem cells
Inventor: BAMDAD CYNTHIA
IPC: C12N5/079
Filed: 2021-06-28
Abstract: The present application discloses a method of producing dopaminergic neurons from human stem cells by adding or increasing concentration of vitamin into neuro basal media at approximately Day 20 +/- 3 of a protocol for differentiating pluripotent stem cells into dopaminergic neurons.
Patent AU-2021322189-A1 (AU)
Title: Methods and devices for gamma correction
Inventor: FETTINGER NATHAN S
IPC: A61B1/05
Filed: 2021-08-03
Abstract: A medical system includes a shaft having a proximal end and a distal end, an imaging device at the distal end of the shaft, and a controller, the controller receives image data comprising pixel data from the imaging device, the pixel data including a plurality of individual pixel values, converts the pixel data from a RGB format to a YC
Patent AU-2021324629-A1 (AU)
Title: Wide cross breeding
Inventor: DAWSON JOHN LUTHER
IPC: A01H5/10
Filed: 2021-08-04
Abstract: Genes found in wild species can provide beneficial traits to domestic crops. For example, wild
Patent AU-2021330784-A1 (AU)
Title: Volumetric immersion system and method
Inventor: CLAPSHAW CHARLES LEON
IPC: G06V20/20
Filed: 2021-08-23
Abstract: A system and method to deliver a volumetric immersive experience to a user (4) via a user's device such as a user's smart phone or similar device (30) where volumetric image data (10), created from a remote environment, is transmitted and received on a user's smart phone (30). The smart phone (30) uses a movement sensor, so that as the device (30) is moved between a first (FIG. 2A) and second (FIG. 3A) position, either a first display mode (FIG. 2B) or a second display mode (FIG. 3B) is displayed on the smart phone display (30). In the first display mode (FIG. 2B), the user typically sees a bubble (2) on their screen (32). The user (4) can then move and experience the effect of being teleported (FIG. 3A) to within the bubble (2) whereby they can pan about and feel immersed within the remote environment (41) from which the volumetric image was created.
Patent AU-2021332357-A1 (AU)
Title: Autonomous subsea tieback enabling platform
Inventor: D'SOUZA RICHARD B
IPC: B63B21/66
Filed: 2021-08-27
Abstract: A system for conveying a fluid produced from at least one producing subsea well to an existing host facility via a flowline includes a support structure having at least a deck, a mooring system, and a plurality of topsides modules. The mooring system anchors the support structure to a seabed and passively positions the support structure proximate to the at least one producing subsea well. The support structure elevates the deck above a water's surface and is normally unmanned. The plurality of topsides modules are disposed on the deck. The topsides modules include at least: a power generation module; a switchgear module a flowline heating module; a chemical injection module; a water injection module; a subsea control module; and a control module that communicates with a remote command center.
Patent AU-2021364548-A1 (AU)
Title: Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer
Inventor: WANG JOSHUA
IPC: A61K39/385
Filed: 2021-10-19
Abstract: Disclosed are virus-inspired compositions and preparation methods thereof, where the compositions comprise mutant papillomavirus L1 proteins that spontaneously form capsid backbones and that are conjugated to a peptide comprising an epitope to form immune redirector capsids (IRCs). The epitopes on the peptides are designed to be recognized by a subject's immune system based on the subject's preexisting immune memory developed from the subject's past exposure to the epitope through infection or vaccination. The mutant papillomavirus LI proteins possess three mutations including an amino-terminal truncation, a carboxy-terminal truncation, and a truncation at helix four. These mutations in the L1 protein yield capsomeres that are form non-canonical T=1 geometry capsid backbones. Disclosed are uses and methods of using the compositions in treating and/or preventing cancers in subjects in need thereof.
Patent AU-2021371034-A1 (AU)
Title: Method and apparatus for rendering color images
Inventor: CROUNSE KENNETH R
IPC: G09G3/20
Filed: 2021-11-02
Abstract: There are provided methods for driving an electro-optic display A method for driving an electro-optic display having a plurality of display pixels, the method comprises receiving an input image, processing the input image to create color separation cumulate, and using a threshold array to process the color separation cumulate to generate colors for the electro-optic display.
Patent AU-2021403027-A1 (AU)
Title: Engineered ssdnase-free crispr endonucleases
Inventor: GARVEY GRAEME S
IPC: C12N15/113
Filed: 2021-12-16
Abstract: The present disclosure provides compositions related to engineered CRISPR endonuclease proteins that have a reduced ability to non-specifically cleave single-stranded DNA (ssDNA) as compared to its reference wildtype protein. This disclosure also provides methods related to the use of, and generation of, engineered CRISPR endonuclease proteins that have a reduced ability to non-specifically cleave ssDNA as compared to its reference wildtype protein.
Patent AU-2021433515-A1 (AU)
Title: Prodrug of celecoxib, preparation method therefor and application thereof
Inventor: WANG YANDONG
IPC: A61K47/54
Filed: 2021-06-08
Abstract: Disclosed are a prodrug of celecoxib represented by formula I, a preparation method therefor and an application thereof. The compound has proper solubility and is relatively stable under storage conditions. Medicine generation experiments show that celecoxib can be detected in eye tissues and is distributed in cornea, conjunctiva and aqueous humor, and the celecoxib achieves a relatively high drug concentration and is an excellent celecoxib prodrug. Moreover, the distribution of control compound SZY1907-P4 is almost not detected, and the concentration of eye drops prepared from the celecoxib in the cornea, conjunctiva and aqueous humor is also relatively low. The compound of formula I has a remarkable absorption advantage, the drug concentration in the eye tissues is remarkably higher than those of a celecoxib group and control group SZY1907-P4, and thus the compound can be prepared into liquid preparations, such as eye drops and injections, for inflammatory reactions.
Patent AU-2021437521-A1 (AU)
Title: Information processing device, information processing method, and program
Inventor: TOKUTAKE Masato
IPC: A01G7/00
Filed: 2021-11-10
Abstract: [Problem] The present invention predicts a production output of a product more accurately. [Solution] Provided is an information processing device for predicting a production output of a product, the information processing device comprising: a region extraction unit that extracts a product region including a product from an image obtained by a photographing device photographing the product; a correction unit that corrects the size of the product region on the basis of a distance from the photographing device to the product, the distance being detected by a distance sensor; and a prediction unit that predicts the production output of the product on the basis of the corrected size of the product region after correction by the correction unit.
Patent AU-2022202324-A1 (AU)
Title: Deployable hardened housing units
Inventor: MCDOWELL DAVID
IPC: H05K5/02
Filed: 2022-04-07
Abstract: The housing relates to apparatus, systems, and methods for robust, adaptable, and deployable computing 
devices and radio systems. An embodiment can be the housing for a C-sUAS that can be deployed to detect, 
identify, locate and defeat hostile sUAss and locate the sUAS operators and that can be ruggedized and 
efficiently deployed for use in various power- and space-constrained mobile platforms and at fixed 
locations. An embodiment can be housing for a C-sUAS that operates under severe environmental 
conditions.